PASADENA, Calif.--(BUSINESS WIRE)--Osmetech plc (AIM: OMH) (“Osmetech” or the “Company”), the international molecular diagnostics company, announces that it has received a Medical Design Excellence Award for innovative device design. The Company has received a 2009 Medical Design Excellence Award for its eSensor® XT-8 molecular diagnostics platform, initially launched with a Warfarin Sensitivity Test.
